Jean‐François Morère

5.3k total citations
216 papers, 4.0k citations indexed

About

Jean‐François Morère is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Jean‐François Morère has authored 216 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Oncology, 88 papers in Pulmonary and Respiratory Medicine and 21 papers in Hepatology. Recurrent topics in Jean‐François Morère's work include Lung Cancer Treatments and Mutations (49 papers), Colorectal Cancer Treatments and Studies (31 papers) and Colorectal Cancer Screening and Detection (29 papers). Jean‐François Morère is often cited by papers focused on Lung Cancer Treatments and Mutations (49 papers), Colorectal Cancer Treatments and Studies (31 papers) and Colorectal Cancer Screening and Detection (29 papers). Jean‐François Morère collaborates with scholars based in France, United States and Switzerland. Jean‐François Morère's co-authors include G. Des Guetz, Bernard Uzzan, Patrick Nicolas, G. Perret, J.L. Breau, Robert Benamouzig, Olivier Schischmanoff, Joseph Gligorov, Vincent Launay‐Vacher and Philippe Beuzeboc and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Jean‐François Morère

202 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐François Morère France 31 2.5k 1.3k 753 666 581 216 4.0k
Karen Borgonovo Italy 33 2.7k 1.1× 1.5k 1.1× 618 0.8× 545 0.8× 639 1.1× 83 3.8k
Gary Richardson Australia 19 2.6k 1.0× 1.2k 0.9× 475 0.6× 734 1.1× 429 0.7× 110 3.8k
Mary Cabiddu Italy 34 2.5k 1.0× 1.3k 1.0× 458 0.6× 649 1.0× 771 1.3× 78 3.9k
Michael Findlay New Zealand 29 1.6k 0.7× 988 0.8× 456 0.6× 601 0.9× 268 0.5× 111 3.3k
Gianpiero Fasola Italy 29 2.0k 0.8× 1.3k 1.0× 377 0.5× 598 0.9× 625 1.1× 175 3.2k
Rodolfo Passalacqua Italy 28 2.1k 0.8× 1.3k 1.0× 509 0.7× 438 0.7× 543 0.9× 140 3.7k
Loren K. Tschetter United States 32 2.2k 0.9× 1.1k 0.8× 406 0.5× 507 0.8× 306 0.5× 61 3.7k
Sercan Aksoy Türkiye 27 1.7k 0.7× 780 0.6× 334 0.4× 554 0.8× 430 0.7× 284 3.6k
Frans Erdkamp Netherlands 26 2.7k 1.1× 1.3k 1.0× 587 0.8× 572 0.9× 562 1.0× 82 3.7k
Jason A. Zell United States 34 2.0k 0.8× 1.7k 1.3× 418 0.6× 527 0.8× 442 0.8× 130 3.7k

Countries citing papers authored by Jean‐François Morère

Since Specialization
Citations

This map shows the geographic impact of Jean‐François Morère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Morère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Morère more than expected).

Fields of papers citing papers by Jean‐François Morère

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐François Morère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Morère. The network helps show where Jean‐François Morère may publish in the future.

Co-authorship network of co-authors of Jean‐François Morère

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐François Morère. A scholar is included among the top collaborators of Jean‐François Morère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐François Morère. Jean‐François Morère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ulusakarya, Ayhan, et al.. (2021). Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience. SHILAP Revista de lepidopterología. 9(4). 2162–2167. 2 indexed citations
2.
Ruiz, Aldrick, Mylène Sebagh, Raphaël Saffroy, et al.. (2019). Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection. BMC Cancer. 19(1). 169–169. 4 indexed citations
3.
Morère, Jean‐François, Jérôme Viguier, Laurent Greillier, et al.. (2018). Indicators of non-uptake of breast cancer screening: Results from the EDIFICE 6 survey. Annals of Oncology. 29. viii752–viii752.
4.
Viguier, Jérôme, et al.. (2018). Colon Cancer Screening Programs: Impact of an Organized Screening Strategy Assessed by the EDIFICE Surveys. Current Oncology Reports. 20(S1). 16–16. 9 indexed citations
5.
Innominato, Pasquale F., Sandra Komarzynski, Ali Mohammad‐Djafari, et al.. (2016). Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project. Journal of Medical Internet Research. 18(11). e305–e305. 23 indexed citations
6.
Ruiz, Aldrick, Dennis A. Wicherts, Mylène Sebagh, et al.. (2016). Liver resection for breast cancer metastases. HPB. 18. e8–e9.
7.
Viguier, Jérôme, Jean‐François Morère, Chantal Touboul, et al.. (2015). Cancer screening in France. European Journal of Cancer Prevention. 24. S68–S72. 5 indexed citations
8.
Soussan, Michaël, Kader Chouahnia, Jacques-Antoine Maisonobe, et al.. (2013). Prognostic implications of volume-based measurements on FDG PET/CT in stage III non-small-cell lung cancer after induction chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 40(5). 668–676. 31 indexed citations
9.
Guetz, G. Des, Bernard Uzzan, Kader Chouahnia, et al.. (2012). Is there a Benefit on Survival of Tyrosine-Kinase Inhibitors Versus Chemotherapy in First Line in Mutated EGFR Patients with Advanced Non-Small Cell Cancer (NSCLC)? A Meta-Analysis. Annals of Oncology. 23. ix414–ix415. 1 indexed citations
10.
Eisinger, François, Jean‐Yves Blay, Xavier Pivot, et al.. (2011). Screening for prostate cancer. European Journal of Cancer Prevention. 20(Supplement 1). S33–S35. 6 indexed citations
11.
Pivot, Xavier, François Eisinger, Jean‐Yves Blay, et al.. (2011). Mammography utilization in women aged 40–49 years. European Journal of Cancer Prevention. 20(Supplement 1). S16–S19. 6 indexed citations
12.
Guetz, G. Des, Bernard Uzzan, Kader Chouahnia, & Jean‐François Morère. (2011). Cardiovascular toxicity of anti-angiogenic drugs. Targeted Oncology. 6(4). 197–202. 45 indexed citations
13.
Guetz, G. Des, Bernard Uzzan, Jean‐François Morère, G. Perret, & Patrick Nicolas. (2010). Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews. 2010(1). CD007046–CD007046. 40 indexed citations
14.
Guetz, G. Des, Olivier Schischmanoff, Patrick Nicolas, et al.. (2009). Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. European Journal of Cancer. 45(10). 1890–1896. 211 indexed citations
15.
Moro‐Sibilot, Denis, et al.. (2007). Quel traitement pour un patient de PS-2/3 ayant un cancer bronchique non à petites cellules (CBNPC) de stade IV ?. Revue des Maladies Respiratoires. 24(8). 3 indexed citations
16.
Launay‐Vacher, Vincent, Stéphane Oudard, Nicolas Janus, et al.. (2007). Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management. Cancer. 110(6). 1376–1384. 337 indexed citations
17.
Chouahnia, Kader, et al.. (2006). Géfitinib et méningite carcinomateuse d’un carcinome bronchique non à petites cellules (CBNPC). Revue des Maladies Respiratoires. 23(2). 149–151. 2 indexed citations
18.
Méric, Jean‐Baptiste & Jean‐François Morère. (2005). Anémie chez les patients atteints de cancer pulmonaire. Bulletin du Cancer. 92(5). 439–444. 6 indexed citations
19.
Saintigny, Pierre, Joseph Gligorov, Frédèric Selle, et al.. (2004). [Dose density and dose intensity in the treatment of breast cancer].. PubMed. 91 Suppl 4. S244–53. 4 indexed citations
20.
Soria, J.C., Marianne Kambouchner, Françoise Morin, et al.. (2003). Long-Term Survival of Patients Given Hormonal Therapy for Metastatic Endometrial Stromal Sarcoma. Medical Oncology. 20(1). 87–94. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Borgonovo Breakdown of academic impact, for papers by Gary Richardson Breakdown of academic impact, for papers by Mary Cabiddu Breakdown of academic impact, for papers by Michael Findlay Breakdown of academic impact, for papers by Gianpiero Fasola Breakdown of academic impact, for papers by Rodolfo Passalacqua Breakdown of academic impact, for papers by Loren K. Tschetter Breakdown of academic impact, for papers by Sercan Aksoy Breakdown of academic impact, for papers by Frans Erdkamp Breakdown of academic impact, for papers by Jason A. Zell
Rankless by CCL
2026